The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
Drug prices have taken center stage since Turing Pharmaceuticals raised the price of its off-patent parasite-fighting drug Daraprim by over 5,000%, …
mvsinha flipped this story into Healthcare•3103d